1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Detalles Bibliográficos
Publicado en:Lancet Vol. 408; no. 10553; pp. 440 - 453
Autores principales: Sotomi, Yohei, Kozuma, Ken, Higuchi, Yoshiharu, Nakazawa, Gaku, Morino, Yoshihiro, Ando, Kenji, Ako, Junya, Tanabe, Kengo, Muramatsu, Takashi, Kobayashi, Ken, Ichibori, Yasuhiro, Ishihara, Takayuki, Hirooka, Keiji, Suwa, Satoru, Warisawa, Takayuki, Naganuma, Toru, Kikuchi, Atsushi, Shutta, Ryu, Okamoto, Naotaka, Tanabe, Yasuhiro
Formato: Journal Article
Publicado: Lancet Aug2026
Acceso en línea:Ver este registro en EBSCOhost